Company Monitoring Page for Bayer

latest headlines for company on cafepharma

Bayer CEO Bill Anderson makes his mark with major restructuring, 'significant' job cuts
Fierce Pharma
Thu, 01/18/24 - 11:03 am
Tags:
Bayer, layoffs, restructuring, Bill Anderson, Pharma CEOs
Bayer and AskBio begin Phase II congestive heart failure treatment trial
Clinical Trials Arena
Fri, 01/12/24 - 09:54 am
Tags:
Bayer, AskBio, congestive heart failure, clinical trials, AB-1002
Bayer's menopausal relief drug succeeds in late-stage trial
Reuters
Mon, 01/8/24 - 11:23 am
Tags:
Bayer, menopause, hot flashes, clinical trials, elinzanetant
Bayer's AskBio checks off another early win for gene therapy platform with Parkinson's safety data
Fierce Biotech
Thu, 01/4/24 - 10:12 am
Tags:
Bayer, AskBio, gene therapy, Parkinson's Disease
Bayer, Now Facing Headwinds, Has A History Of Bold Innovation
Forbes
Tue, 11/28/23 - 10:22 am
Tags:
Bayer, innovation
Bayer's trial flop, courtroom setback could restrict CEO's options amid strategic review: analyst
Fierce Pharma
Tue, 11/21/23 - 10:43 pm
Tags:
Bayer, Pharma CEOs, Bill Anderson, asundexian
Bayer's blood thinner fails Eliquis test, sinking phase 3 trial and denting $5B sales forecast
Fierce Biotech
Mon, 11/20/23 - 11:41 am
Tags:
Bayer, asundexian, bloodthinners, Eliquis, clinical trials
J&J and Bayer's Xarelto proves its worth across PAD subgroups in 2 new analyses
Fierce Pharma
Tue, 11/14/23 - 09:56 pm
Tags:
JNJ, Bayer, Xarelto, blood thinners, AHA, peripheral artery disease
Bayer to withdraw follicular lymphoma therapy after trial failure
Clinical Trials Arena
Tue, 11/14/23 - 09:37 am
Tags:
Bayer, Aliqopa, relapsed follicular lymphoma, clinical trials
European regulator endorses high-dose version of Bayer eye drug Eylea
Reuters
Fri, 11/10/23 - 10:09 am
Tags:
Bayer, EMA, Eylea, Roche
Bayer CEO Anderson says 'radical realignment' is underway
Fierce Pharma
Wed, 11/8/23 - 12:05 pm
Tags:
Bayer, Pharma CEOs, Bill Anderson, layoffs
Bayer adds a new life science incubator in China
Pharmaphorum
Tue, 11/7/23 - 10:04 am
Tags:
Bayer, Co.Lab, incubators, China, oncology, cell therapy, gene therapy
Bayer doubles down on Factor XIa with new phase 3 trial
Pharmaphorum
Mon, 11/6/23 - 09:56 am
Tags:
Bayer, clinical trials, asundexian, Factor Xa inhibition, atrial fibrillation
Novo Nordisk, with coffers filling with cash, buys rival to Bayer's kidney drug Kerendia in $1.3B deal
Fierce Biotech
Mon, 10/16/23 - 10:24 am
Tags:
Novo Nordisk, KBP Biosciences, Bayer, chronic kidney disease, Kerendia, ocedurenone, hypertension
Bayer christens $250M cell therapy 'launch facility' in Berkeley
Fierce Pharma
Tue, 10/10/23 - 11:55 am
Tags:
Bayer, cell therapy, Berkeley, Californi, BlueRock Therapeutics
Bayer CEO plots management cuts as first step in larger overhaul
Fierce Pharma
Fri, 09/15/23 - 11:53 am
Tags:
Bayer, Pharma CEOs, Bill Anderson, layoffs
Bayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
ForbesBayer Is Rapidly Expanding Its Footprint With Artificial Intelligence
Tue, 09/5/23 - 11:21 am
Tags:
Bayer, artificial intelligence, Google
Bayer looks to expand Kerendia label to include heart failure
Clinical Trials Arena
Fri, 09/1/23 - 12:38 pm
Tags:
Bayer, Kerendia, clinical trials, heart failure
Bayer Pushes Ahead With Parkinson’s Cell Therapy on Heels of Positive Phase 1 Data
MedCity News
Mon, 08/28/23 - 08:21 pm
Tags:
Bayer, cell therapy, Parkinson's Disease, clinical trials
Bayer preps for phase 2 after Parkinson's cell therapy clears safety bar in early-stage study
Fierce Biotech
Mon, 08/28/23 - 11:37 am
Tags:
Bayer, Parkinson's Disease, cell therapy, bemdaneprocel, BlueRock Therapeutics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.